Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LENZ has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
LENZ stock price ended at $28.47 on Thursday, after losing-0.16%
The LENZ Therapeutics Inc stock price decreased by -0.16% on the last trading day (01 May 2025), dropping from 26.53 to 28.515. Throughout the last trading session, the stock experienced a fluctuation of 13.38% , ranging from a day low of $25.49 to a day high of 28.9. The price has declined in 3 of the last 10 days, resulting in a total change of 19.36% during this period. On the last day, trading volume decrease by 114.43K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 286.60K shares were traded, amounting to approximately 8.01M.
LENZ Technical Signals
LENZ(LENZ Therapeutics Inc Corp) has 6 buy signals and 3 sell signals now. The current trend is uptrend starting from 2025-04-09. The total price change during this trend is +39.64%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of LENZ over the last 5 trading days is 9.57M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
LENZ Moving Average Analysis
LENZ Therapeutics Inc's overall moving average trend leans more bullish as of Thursday, May 1, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $29.977486666666668, and $32.647666666666666. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $21.337846666666668, and $18.66766666666667. A break-down below any of these levels will issue sell signals.
LENZ Short Selling Analysis
The short sale ratio of LENZ Therapeutics Inc(LENZ) as of 29 Apr 2025 is 39.48%, rising from last trading day. With increasing price from 27.27 to 26.63. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Buy
Sell
3
Buy
6
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
6 Bullish Signals
6 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
2.931
Bullish
Momentum (10 days)
MOM_10 > 0
4.625
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
1.044
Bullish
Closing price
close > fibonacci_R1
28.515
Bullish
Moving Average
Price crosses above 5-day SMA
--
Bullish
Moving Average
10-day SMA crosses above 200-day SMA
--
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 > 80
88.799
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
83.587
Bearish
Williams %R (14 days)
WILLR_14 > -20
-3.476
Bearish
LENZ Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to LENZ Therapeutics Inc(LENZ), our algorithm predicts LENZ's 1-month price at $26.73, with an -0.51%downwardshift. Using a similarity score up to 94.98%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for LENZ Therapeutics Inc (LENZ.O) stock, as of Sunday, April 27, 2025 , forecasts a -0.51% change over the next month, based on its high correlation with VRNS.O stock patterns. The similarity between their price movements over the analyzed periods is 94.98%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
LENZ
Future prediction
Up: -0.51%
VRNS
Down: -0.51%Similarity: 94.98%
Name
Similarity
Up/Down
VRNS.O
94.98%
-0.51%
UDR.N
94.82%
-3.66%
HWM.N
94.70%
+11.56%
HAL.N
94.63%
-16.01%
PYPL.O
94.39%
+2.67%
IIIN.N
94.34%
+29.47%
ICFI.O
94.31%
+18.37%
BWXT.N
94.25%
+2.04%
SCM.N
94.25%
+8.12%
PAMT.O
94.00%
+9.68%
LENZ Seasonality Analysis
Based on LENZ's historical stock price data across all years, the probability of a positive return in May is0.00%, suggesting it maynotbe an ideal month to invest in LENZ. In contrast,Octoberoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying LENZ Therapeutics Inc (LENZ.O) stock in October has the highest probability of a positive return (75.00%), while May has the lowest probability (0.00%).
Performance Seasonality
The chart shows LENZ Therapeutics Inc. (LENZ)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy LENZ Therapeutics Inc (LENZ.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LENZ has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying LENZ Therapeutics Inc (LENZ.O) stock in a year?
The radar chart shows that buying LENZ Therapeutics Inc (LENZ.O) stock in October has the highest probability of a positive return (75.00%), while May has the lowest probability (0.00%).
How has LENZ Therapeutics Inc. (LENZ)'s stock price performed over the past three years?
LENZ's stock price fell by -18.38% in 2023,increased by 705.07% in 2024, and went up by 0.64% in 2025.
Which bull technical signals does LENZ have?
Bullish technical signals of LENZ include: AO_5_34 > 0, MOM_10 > 0, MACD_12_26_9 > 0, close > fibonacci_R1, Price crosses above 5-day SMA, 10-day SMA crosses above 200-day SMA.
Is LENZ a buy based on overall technical signals summary?
LENZ has 6 buy signals and 3 sell signals now. Overall the technical rating for LENZ is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of LENZ.
What is the trend of LENZ Therapeutics Inc (LENZ)'s moving average?
LENZ Therapeutics Inc's overall moving average trend leans more bullish as of May 01 2025, with 2 negative signals and 2 positive signal.
What is price prediction for LENZ stock next month?
The price prediction chart for LENZ Therapeutics Inc (LENZ.O) stock, as of April 27 2025, forecasts a -0.51% change over the next month, based on its high correlation with VRNS stock patterns. The similarity between their price movements over the analyzed periods is 94.98%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for LENZ Stock?
The price prediction for LENZ stock in 2025 is **$35 per share**. This forecast is based on strong analyst sentiment, with Piper Sandler raising its price target to $51 and Citigroup increasing it to $47, both maintaining a "Strong Buy" rating. The upcoming FDA decision on August 8, 2025, for LNZ100, a promising treatment for presbyopia, is a significant catalyst expected to drive growth. Analysts project substantial revenue potential, with sales estimated to reach $58 million in 2026 and $592 million by 2035. Technical indicators also support this bullish outlook, with LENZ trading above key moving averages and showing positive momentum.
What is price prediction 2030 for LENZ Stock?
The price prediction for LENZ stock by 2030 is expected to reach **$32.92**, driven by strong market position and upcoming product launches. By 2030, LENZ could potentially reach **$45** due to its positive outlook and growth prospects. The stock is currently testing Fibonacci resistance levels, with a pivot at $25.02.